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Abstract
Background: Mutations in mediator of RNA polymerase II transcription subunit 12 
homolog (MED12, OMIM 300188) cause X‐linked intellectual disability (XLID) 
disorders including FG, Lujan, and Ohdo syndromes. The Gli3‐dependent Sonic 
Hedgehog (SHH) signaling pathway has been implicated in the original FG syn-
drome and Lujan syndrome. How are SHH‐signaling defects related to the complex 
clinical phenotype of MED12‐associated XLID syndromes are not fully understood.
Methods: Quantitative RT‐PCR was used to study expression levels of three SHH‐
signaling genes in lymophoblast cell lines carrying four MED12 mutations from four 
unrelated XLID families. Genotype and phenotype correlation studies were per-
formed on these mutations.
Results: Three newly identified and one novel MED12 mutations in six affected 
males from four unrelated XLID families were studied. Three mutations (c.2692A>G; 
p.N898D, c.3640C>T; p.R1214C, and c.3884G>A; p.R1295H) are located in the LS 
domain and one (c.617G>A; p.R206Q) is in the L domain of MED12. These muta-
tions involve highly conserved amino acid residues and segregate with ID and related 
congenital malformations in respective probands families. Patients with the 
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1 |  INTRODUCTION
Mediator of RNA polymerase II transcription subunit 12 ho-
molog (MED12) encodes a core component of a multi‐sub-
unit mediator complex, which includes MED12, MED13, 
cyclin C, and CDK8 (Yin & Wang, 2014). Mediator is a 
large, evolutionarily conserved protein complex that plays 
an important role in gene regulation (Yin & Wang, 2014). 
The mediator complex consists of approximately 30 subunits 
that are assembled into four functional modules interacting 
with signaling proteins in the vertebral endoderm (Shin et al., 
2008) and neuronal development (Wang, Yang, Uno, Roeder, 
& Guo, 2006) and the canonical Wnt signaling pathway 
(Rocha, Scholze, Bleiss, & Schrewe, 2010). GLI family zinc 
family protein 3 (GLI3) binds directly to the PQL domain 
of MED12, which suppresses the enhanced GLI3‐dependent 
transactivation induced by Sonic hedgehog (SHH) signal-
ing (Zhou, Kim, Ishii, & Boyer, 2006). SHH signaling has 
critical functions in the development of the central nervous 
system including neural tube patterning, neuronal cell differ-
entiation and survival (Ho & Scott, 2002).
MED12 mutations have been associated with a wide phe-
notypic spectrum of MED12‐related disorders (Charzewska 
et al., 2018). Somatic mutations in MED12 have been re-
ported in leiomyosarcoma (Ravegnini et al., 2013) and 
prostate cancer (Kämpjärvi et al., 2015). Germline MED12 
mutations were originally found in patients with FG and 
Lujan syndromes (Risheg et al., 2007; Schwartz et al., 2007) 
and later in patients with X‐linked Ohdo syndrome and iso-
lated XLID disorders (Bouazzi, Lesca, Trujillo, Alwasiyah, 
& Munnich, 2015; Callier et al., 2013; Isidor et al., 2013; 
Langley et al., 2015; Lesca et al., 2013; Tzschach et al., 2015; 
Vulto‐van Silfhout et al., 2013; Yamamoto & Shimojima, 
2015). Mutations that cause FG syndrome (p.R961W) and 
Lujan syndrome (p.N1007S) were found to compromise the 
mediator‐imposed constraint on GLI3‐dependent SHH sig-
naling and result in increased transcript levels for multiple 
GLI3 target genes in lymphoblasts from patients (Zhou et al., 
2012). How GLI3–SHH‐signaling defects relate to the com-
plex clinical phenotypes of MED12‐associated XLID syn-
dromes are not known.
We report genetic and functional characterizations of 
four MED12 mutations in patients with XLID disorders. 
Patients with LS‐domain mutations show ID and congenital 
malformations overlapping with FG and Lujan syndromes. 
Transcript levels of three SHH/GLI3‐signaling genes, BMP4 
(OMIM112262), CREB5, NEUROG2 (OMIM606624), were 
found to be significantly elevated in lymphoblasts from pa-
tients with these mutations. The patient with a change in the 
L domain only had elevated expression of BMP4 and pre-
sented with ID and predominant psychiatric phenotypes. 
These results expand genotype and phenotype spectrums of 
MED12‐mediated XLID syndromes and support a critical 
role of MED12‐regulated Gli3‐dependent SHH signaling in 
the expression of disease phenotypes.
2 |  MATERIALS AND METHODS
2.1 | Study patients and controls
Patients with XLID and control males with normal cogni-
tive function were recruited by the Greenwood Genetic 
Center (Greenwood, SC) and the Johns Hopkins University 
(Baltimore, MD). Human subject research protocols for these 
LS‐domain mutations share many features of FG syndrome and some features of 
Lujan syndrome. The patient with the L‐domain mutation presented with ID and 
predominant neuropsychiatric features but little dysmorphic features of either FG or 
Lujan syndrome. Transcript levels of three Gli3‐dependent SHH‐signaling genes, 
CREB5, BMP4, and NEUROG2, were determined by quantitative RT‐PCR and found 
to be significantly elevated in lymphoblasts from patients with three mutations in the 
MED12‐LS domain.
Conclusions: These results support a critical role of MED12 in regulating Gli3‐de-
pendent SHH signaling and in developing ID and related congenital malformations in 
XLID syndromes. Differences in the expression profile of SHH‐signaling genes po-
tentially contribute to variability in clinical phenotypes in patients with MED12‐re-
lated XLID disorders.
K E Y W O R D S
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studies were approved by Institutional Review Boards (IRBs) 
at the respective institutions. An informed consent was ob-
tained from each study patient and/or their parents or legal 
guardians. These patients were all evaluated by clinical ge-
neticists and underwent comprehensive laboratory studies 
for ID. All patients were found to have a normal karyotype, 
negative molecular testing for fragile X syndrome, and a neg-
ative screen for common inborn errors of metabolism. For 
each individual, 5–10 ml of blood was collected to establish 
EB‐transformed lymphoblast cell lines. Genomic DNA sam-
ples from affected probands males with XLID were used for 
sequencing and mutation screening. A cohort of >800 males 
with normal cognitive function from the Greenwood Genetic 
Center and Johns Hopkins University were used as controls. 
Additional reference data include the male portion of sam-
ples (n = 525) from the 1,000 Genomes project (Integrated 
Phase 1, version 3:20101123).
2.2 | X chromosome exome sequencing and 
exon‐based resequencing
Sequence libraries were prepared using a TruSeqTM Genomic 
DNA Library Preparation kit (Illumina), enriched for the 
human X chromosome Exome using a SureSelect Target 
Enrichment kit (Agilent), and sequenced using the 75 bp 
pair‐end sequence module on the HiSeq2000 (Illumina). 
Alignment of the fastq reads, base recalibration, and vari-
ant calling were completed using Bowtie2 and Unified 
Genotyper (GATK). Disease‐causing mutations were en-
riched using the nonclinical portion of the dbSNP, the male‐
restricted portion of the 1,000 Genomes, Exome Variant 
Server datasets, and an affected sib‐pair/cross‐cohort‐based 
algorithm (Niranjan et al., 2015). Evolutionary conserva-
tion of the amino acid residues involved in the identified 
mutations was evaluated by multiple sequence alignment of 
HomoloGene (http://www.ncbi.nlm.nih.gov/homologene/). 
Standard bioinformatics algorithms including SIFT (http://
sift.jcvi.org) and PolyPhen‐2 (http://genetics.bwh.harvard.
edu/pph2/index.shtml) were used to predict the functional 
impact of the identified mutations (Niranjan et al., 2015). 
Additional exon‐based resequencing was conducted to iden-
tify novel MED12 mutations in patients with intellectual dis-
ability and a pedigree consistent with X‐linked inheritance 
(Raymond et al., 2007). Sanger sequencing was used for 
validation, segregation analysis, and polymorphism studies 
of each mutation using the BigDye Terminator v3.1 Cycle 
Sequencing Kit on an ABI3100 automatic DNA analyzer 
(Applied Biosystems) following manufacturer's instruction. 
Variant analysis of MED12 (NM_005120.2) was completed 
using standard sequence alignment software (CodonCode 
and MacVector) followed by manual investigations of the 
chromatograms.
2.3 | Real‐time quantitative PCR analysis 
for transcript levels of SHH‐signaling genes
EBV‐transformed lymphoblastoid cell lines from patients 
and controls were cultured in RPMI 1640 medium with 15% 
FBS (Sigma) and 1% penicillin–streptomycin (100 U penicil-
lin; 0.1 mg/ml streptomycin) at 37°C, 10% CO2. Cells were 
harvested at log phase. Total RNA was prepared from cul-
tured lymphoblasts from individual patients and normal con-
trols using a Qiagen RNA preparation kit. cDNA from these 
samples was synthesized using a M‐MLV RT kit (Promega). 
Real‐time qPCR was conducted using an absolute SYBR 
Green mix (Applied Biosystems) in an iCycler (BioRad). 
After initial denaturation at 95.0ºC for 3 min, the reaction 
was cycled for 35 times at 95.0ºC for 30 s and 60.0ºC for 
45 s. Input samples were normalized using a simultaneous 
quantification of β‐actin. qPCR Primers used in this study are 
given in Table S1. Lymphoblast cell lines from three unre-
lated normal males and from the original Lujan family with 
a p.N1007S mutation were used as controls. Each data set 
for the transcript levels was generated from triplicate studies. 
Statistical analyses of qPCR data were performed using two‐
tailed t test for comparison of the means of two independent 
samples. Data were presented as mean ± SEM; p < 0.05 was 
considered statistically significant.
3 |  RESULTS
3.1 | Identification and pedigree analysis of 
MED12 mutations in XLID families
Exon resequencing of 718 X‐linked genes (Tarpey et al., 
2009) found a c.3884G>A; p.R1295H mutation in two af-
fected brothers (II‐3 and II‐6) and their mother who is het-
erozygous (K9338) (Figure 1a). Sequencing of MED12 in a 
cohort of XLID families identified c.617G>A; p.R206Q mu-
tation in an affected male and his unaffected mother (K8935) 
(Figure 1b) and a c.2692A>G; p.N898D mutation in an af-
fected male and his unaffected mother in a family suspected 
to have FG syndrome (K9467) (Figure 1c). X chromosome 
exome sequencing identified a c.3640C>T; p.R1214C in two 
affected brothers and their unaffected mother in an XLID 
family (L08–2677) (Niranjan et al., 2015) (Figure 1d). The 
p.N898D, p.R1214C, and p.R1295H mutations are located 
in the LS domain while the p.R206Q mutation is located 
in the L domain of MED12 (Figure 2a). All four mutations 
involve highly conserved amino acid residues during evolu-
tion, and none was found in >1,325 normal X chromosomes 
(Figure 2b). The Combined Annotation Dependent Depletion 
(CADD) scores for all four mutations are in the range of 
23.2 to 31 suggesting a high likelihood of deleterious ef-
fects (Table 1) (GRCh37‐v1.4, https://cadd.gs.washington.
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F I G U R E  1  Pedigree Analysis and Clinical Features of XLID Probands with MED12 Mutations. Panel a: Segregation of c.3884G>A; 
p.R1295H in pedigree of K9338; confirmed genotypes (WT, G; mutation, A) are indicated below individual symbols; skewed X chromosome 
inactivation data in female carriers are provided for II2, II4, III2. Facial features of one affected male are shown. Panel b: Segregation of c.617G>A; 
p.R206Q in pedigree K8935. Confirmed genotypes (WT, G; mutation, A) were shown below the affected male. Facial features of the affected 
male are shown. Panel c: Segregation of c.2692A>G; p.N898D in pedigree K9467. Confirmed genotypes (WT, A; mutation, G) are indicated 
below individual symbols; data for skewed X chromosome inactivation are provided for II2, II3, and II4. Facial features of the affected male are 
shown. Panel d: Segregation of c.3640C>T; p.R1214C in pedigree of LO8–2677. Confirmed genotypes (WT, C; mutation, T) are indicated below 
individual symbols. For all pedigrees: square symbol, male; circle symbol, female; open symbol, unaffected; filled symbol, affected; circle with a 
center dot, confirmed female carrier
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edu).3.2 | Increased expression of SHH‐signaling genes 
in lymphoblasts with LS‐domain mutations
Increased transcript levels for SHH‐signaling genes have 
been reported in cell lines from patients with FG and Lujan 
syndrome (Zhou et al., 2012). We thus performed a real‐time 
qRT‐PCR quantification of transcript levels of three genes 
(CREB5, BMP4, and NEUROG2) in the SHH‐signaling 
pathway in lymphoblasts from patients with four MED12 
mutations (Figure 3). Transcript levels for these genes are sig-
nificantly increased for the three LS‐domain mutations. The 
L‐domain mutation, p.R206Q, shows only modest increase in 
the transcript of BMP4 (Figure 3). Expression of HPRT1, a 
house‐keeping gene not known to be regulated by SHH/GLI3 
signaling, showed no significant difference in lymphoblast 
cell lines between normal controls and patients with these 
MED12 mutations (Figure S1). These results support that the 
MED12‐LS domain plays a major role in the negative regula-
tion of Gli3‐dependent SHH signaling (Zhou et al., 2012), 
and these mutations found in patients with ID and congenital 
malformations show deleterious effects on MED12 function.
3.3 | Expanding phenotypic spectrum of 
MED12‐related XLID disorders
MED12‐related XLID disorders exhibit a wide phenotypic 
spectrum in impairment of cognition, behavioral defects, and 
multiple congenital anomalies (Graham & Schwartz, 2013). 
“The patient with p.N898D mutation presented with mac-
rocephaly, tall and broad forehead, downslanting palpebral 
fissures, small and posteriorly rotated ears, broad big toes, 
imperforate anus and constipation, and behavioral profile that 
mostly resemble patients with FG syndrome. Patients with 
F I G U R E  2  Disease‐causing MED12 Mutations Involve Highly Conserved Amino Acid Residues and are Clustered around the 
Established Functional Domains. Panel a: Distribution of ID‐associated mutations over functional domains of MED12. Known ID‐associated 
mutations(Graham & Schwartz, 2013) are presented above and the four mutations of MED12 (NM_005120.2) in this study are below the symbols 
of protein domains. Note that 3 mutations p.N898D, p.R1214C, and p.R1295H are located within the LS domain where the recurrent mutations for 
FG and Lujan syndromes occur and one, p.R206Q, is located within the L domain. L, leucine‐rich domain; LS, leucine serine‐rich domain; PQL, 
proline‐, glutamine‐, and leucine‐rich domain; OPA, glutamine‐rich domain. Panel b. MED12 mutations involve highly evolutionarily conserved 
amino acid residues as shown in a multispecies sequence alignment. Mutations responsible for FG, Lujan, and Ohdo syndrome are based on 
previously published studies(Graham & Schwartz, 2013)
6 of 10 |   SRIVASTAVA eT Al.
T A B L E  1  Clinical features of MED12 mutations responsible for XLID syndromes
Pedigree ID_Syndrome FG syndrome Lujan syndrome XLID_K8935_II‐1 XLID_K9467_III‐1 XLID_L08‐2677_II‐1 XLID_L08‐2677_II‐2 XLID_K9338_II‐1 XLID_K9338_II‐6
GRCh37‐v1.4 ChrX:70340884 ChrX:70346825 ChrX:70349228 ChrX:70349228 ChrX:70349901 ChrX:70349901
Mutation c.617G>A; p.R206Q c.2692A>G; p.N898D c.3640C>T; p.R1214C c.3640C>T; p.R1214C c.3884G>A; p.R1295H c.3884G>A; p.R1295H
CADDa 23.2 26.2 31 31 23.4 23.4
Evaluation Age (year) 15 17 14 11
Weight (kg) 5th centile 5th% failure to thrive failure to thrive
Height (cm) 10 th centile 5th% 25th centile (at 54 years) 60th centile (at 49 years)
OFC (cm) Relative macrocephaly Macrocephaly Macrocephaly >97th centile 50–75th centile 10–25th centile Macrocephalic 75th centile (at 49 years)
Appearance Marfanoid habitus Height and weight 
>97%tile
Asthenic build Asthenic build Asthenic build Poor muscle bulk
Motor Development Delayed walking Delayed walking Delayed walking Delayed; clumsy walking Delayed; walking after 2 years
Language Development Delayed; first word at 
3 years
Delayed speech Delayed speech Speech unintellligible 
until 5 years
Delayed speech
Intellectual Disability Moderate to severe Mild to moderate Mild to moderate (IQ 
40–85)
Mild to moderate (IQ 
58)
Mild to moderate Mild to moderate Mild to moderate (IQ 58) Moderate
Behaviors Friendly personality 


















Craniofacial Tall forehead Frontal hair 
upsweep
Tall forehead Tall and broad forehead 
Frontal upsweep
Tall forehead Tall forehead
Long and narrow face 
Maxillary hypoplasia
Long and narrow face 
Maxillary hypoplasia
Maxillary hypoplasia Long and narrow face 
Maxillary hypoplasia
Long and narrow face Long face; prominent 
supraorbital ridge















Small prominent ears with 
simplified helical pattern
Hypernasal speech Astigmatism, exotropia, 
and mild hyperopia
Small posteriorly rotated 
ears





Dental crowding and 
prognathism
High‐arched palate High‐arched palate
Musculoskeletal Pectus extracavatum 
Scoliosis 
Joint contracture
Mild pectus carinatum Severe pectus carinatum 
Moderate scoliosis 
Mild contracture of elbows
Thoracic kyphosis; Marked thoracic kyphosis
Broad thumb; syndactyly; 
persistent fetal finger pads
Long extensible digits; 
broad thumbs
Long hands (length 
>97th%)
Angulation of distal 
phalanges; broad big 
toes
Hand length: 25–50th centile 
Middle finger length: 50th centile Arm 
span‐to‐height ratio: 1.03 
Upper‐to‐lower segment ratio: 0.89
Hand length: 25–50th centile 
Middle finger length: 25–50th 
centile Arm span‐to‐height 
ratio: 1.05 
Upper‐to‐lower segment ratio: 
0.71 
Slender fingers; hyperextensi-
bility; fifth finger clinodactyly; 
pes planus
Pes cavus Finger contractures at PIP joints; 
Hammer toes; wide gap between 
first and second toes
Gastrointestinal Anal anomaly; constipation Imperforate anus 
Constipation
Severe constipation; megacolon Anal stricture and 
stenosis; umblical and 
inguinal hernia
Constipation
Genitourinary Genitourinary anomaly Hydroceles Cryptorchidism Posteriour urethral valves Undescended testicles Undescended testicles
Neurological Hypotonia Hypotonia Hypotonia Seizure disorders; wide spaced gait Seizure disorders Uncoordinated gait; 
hearing loss
Hypotonia; hearing loss
Agenesis of corpus callosum Agenesis of corpus 
callosum
Normal head CT Normal head CT Agenesis of corpus 
callosum; enlarged 
ventricules on MRI
aCombined Annotation Dependent Depletion (CADD); https://cadd.gs.washington.edu 
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T A B L E  1  Clinical features of MED12 mutations responsible for XLID syndromes
Pedigree ID_Syndrome FG syndrome Lujan syndrome XLID_K8935_II‐1 XLID_K9467_III‐1 XLID_L08‐2677_II‐1 XLID_L08‐2677_II‐2 XLID_K9338_II‐1 XLID_K9338_II‐6
GRCh37‐v1.4 ChrX:70340884 ChrX:70346825 ChrX:70349228 ChrX:70349228 ChrX:70349901 ChrX:70349901
Mutation c.617G>A; p.R206Q c.2692A>G; p.N898D c.3640C>T; p.R1214C c.3640C>T; p.R1214C c.3884G>A; p.R1295H c.3884G>A; p.R1295H
CADDa 23.2 26.2 31 31 23.4 23.4
Evaluation Age (year) 15 17 14 11
Weight (kg) 5th centile 5th% failure to thrive failure to thrive
Height (cm) 10 th centile 5th% 25th centile (at 54 years) 60th centile (at 49 years)
OFC (cm) Relative macrocephaly Macrocephaly Macrocephaly >97th centile 50–75th centile 10–25th centile Macrocephalic 75th centile (at 49 years)
Appearance Marfanoid habitus Height and weight 
>97%tile
Asthenic build Asthenic build Asthenic build Poor muscle bulk
Motor Development Delayed walking Delayed walking Delayed walking Delayed; clumsy walking Delayed; walking after 2 years
Language Development Delayed; first word at 
3 years
Delayed speech Delayed speech Speech unintellligible 
until 5 years
Delayed speech
Intellectual Disability Moderate to severe Mild to moderate Mild to moderate (IQ 
40–85)
Mild to moderate (IQ 
58)
Mild to moderate Mild to moderate Mild to moderate (IQ 58) Moderate
Behaviors Friendly personality 


















Craniofacial Tall forehead Frontal hair 
upsweep
Tall forehead Tall and broad forehead 
Frontal upsweep
Tall forehead Tall forehead
Long and narrow face 
Maxillary hypoplasia
Long and narrow face 
Maxillary hypoplasia
Maxillary hypoplasia Long and narrow face 
Maxillary hypoplasia
Long and narrow face Long face; prominent 
supraorbital ridge















Small prominent ears with 
simplified helical pattern
Hypernasal speech Astigmatism, exotropia, 
and mild hyperopia
Small posteriorly rotated 
ears





Dental crowding and 
prognathism
High‐arched palate High‐arched palate
Musculoskeletal Pectus extracavatum 
Scoliosis 
Joint contracture
Mild pectus carinatum Severe pectus carinatum 
Moderate scoliosis 
Mild contracture of elbows
Thoracic kyphosis; Marked thoracic kyphosis
Broad thumb; syndactyly; 
persistent fetal finger pads
Long extensible digits; 
broad thumbs
Long hands (length 
>97th%)
Angulation of distal 
phalanges; broad big 
toes
Hand length: 25–50th centile 
Middle finger length: 50th centile Arm 
span‐to‐height ratio: 1.03 
Upper‐to‐lower segment ratio: 0.89
Hand length: 25–50th centile 
Middle finger length: 25–50th 
centile Arm span‐to‐height 
ratio: 1.05 
Upper‐to‐lower segment ratio: 
0.71 
Slender fingers; hyperextensi-
bility; fifth finger clinodactyly; 
pes planus
Pes cavus Finger contractures at PIP joints; 
Hammer toes; wide gap between 
first and second toes
Gastrointestinal Anal anomaly; constipation Imperforate anus 
Constipation
Severe constipation; megacolon Anal stricture and 
stenosis; umblical and 
inguinal hernia
Constipation
Genitourinary Genitourinary anomaly Hydroceles Cryptorchidism Posteriour urethral valves Undescended testicles Undescended testicles
Neurological Hypotonia Hypotonia Hypotonia Seizure disorders; wide spaced gait Seizure disorders Uncoordinated gait; 
hearing loss
Hypotonia; hearing loss
Agenesis of corpus callosum Agenesis of corpus 
callosum
Normal head CT Normal head CT Agenesis of corpus 
callosum; enlarged 
ventricules on MRI
aCombined Annotation Dependent Depletion (CADD); https://cadd.gs.washington.edu 
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p.R1214C and p.R1295H mutations presented with features 
that resemble both Lujan and FG syndromes. These features 
include craniofacial features, behavioral profile, anal anoma-
lies, and severe constipation that are common in patients with 
FG syndrome as well as long and thin face, high‐arch palate, 
asthenic body build, reduced muscle mass, long and slender 
fingers, joint hyperextensibility that are seen in patients with 
Lujan syndrome. The patient with p.R206Q mutation pre-
sented with ID and predominant neuropsychiatric phenotype 
but without significant dysmorphic features or congenital 
malformations of either FG or Lujan syndromes (Table 1).”
4 |  DISCUSSION
Classical features of FG syndrome include ID, craniofacial 
features such as macrocephaly, prominent forehead, hyper-
telorism, downslanting palpebral fissures, small ears, mus-
culoskeletal anomalies such as pectus deformities, broad 
thumbs, gastrointestinal defects such as anal anomaly with 
severe constipation, and a characteristic behavioral profile 
with friendly personality and short attention span (Clark 
et al., 2009; Opitz & Kaveggia, 1974). A recurrent muta-
tion, p.R961W, in the MED12‐LS domain was identified 
in the original and five additional families with clinical 
features suggestive of FG syndrome (Risheg et al., 2007). 
Patients from the original Lujan syndrome family presented 
with X‐linked intellectual disability, hypotonia, macro-
cephaly, marfanoid habitus with long fingers with exten-
sible joints, craniofacial features such as long and narrow 
face, high‐arched palate with hypernasal voice, and struc-
tural brain anomalies such as agenesis of corpus callosum 
(Lujan, Carlin, & Lubs, 1984). A single missense mutation 
in MED12‐LS domain, N1007S, has been identified in the 
original Lujan syndrome family (Schwartz et al., 2007). The 
patient with p.N898D mutation presented with features that 
mostly resemble FG syndrome; patients with p.R1214C and 
p.R1295H mutations presented with features that overlap 
with FG and Lujan syndromes; the patient with p.R206Q 
mutation showed severe psychiatric phenotype but with-
out characteristic dysmorphic features or malformations of 
either FG syndrome or Lujan syndromes (Table 1). Taken 
together, our current studies on these four MED12 muta-
tions expand the genotype and phenotype spectrums of the 
MED12‐related X‐linked ID disorders.
MED12 consists of several structurally and functionally 
defined domains including a N‐terminal leucine‐rich do-
main (L), a leucine‐ and serine‐rich domain (LS), a proline‐, 
F I G U R E  3  Real‐time Quantitative PCR Analysis of Transcript Levels of Three SHH‐Signaling Genes in Lymphoblasts from Patients with 
XLID. Note that compared to normal control lymphoblasts (n = 3), the transcript levels for all three genes, CREB5, BMP4, NEUROG2 in the 
SHH‐signaling pathway show a significant increase in lymphoblasts carrying three MED12 mutations (p.N898D; p.R1214C; and p.R1295H) within 
the LS domain but minimal changes for the mutation, p.R206Q, within the L domain. N1007S is the lymphoblast cell line from the probands of 
the original Lujan syndrome family(Schwartz et al., 2007). Means ± SEM from the triplicate studies of each lymphoblast cell line were shown. **, 
p < 0.01; ***, p < 0.001
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glutamine‐, and leucine‐rich domain (PQL), and a C‐terminal 
opposite paired domain (OPA). The PQL domain mediates 
protein–protein interaction while function for other domains 
remain largely unknown (Zhou et al., 2006). Classical FG and 
Lujan syndromes are caused by mutations in the LS domain, 
which is highly conserved (Figure 2a). Previous studies have 
shown that MED12 mutations in FG and Lujan syndromes 
disrupt a mediator‐imposed constraint on GLI3‐dependent 
SHH signaling (Zhou et al., 2012). Expression levels of mul-
tiple SHH/GLI3 target genes including GLI3, ASCL1, BMP4, 
CREB5, and NEUROG2 were significantly elevated in pa-
tients’ lymphoblast cell lines (Zhou et al., 2012). Increased 
expression of these genes was inhibited by a SHH antagonist, 
cyclopamine, suggesting that their induction was SHH/GLI3 
dependent (Zhou et al., 2012).
By examining transcript levels of three Gli3‐dependent 
SHH‐signaling genes, CREB5, BMP4, and NEUROG2, 
in lymphoblasts, we found that p.N898D, p.R1214C, and 
p.R1295H mutations are associated with increased expres-
sion of all three genes. Interestingly, p.N898D mutation was 
found to associate with a significant increase in expression of 
BMP4 but moderate increase in expression of NEUROG22. 
In contrast, p.R1214C and p.R1295H mutations were found 
to associate with significant increase in NEUROG2 but mod-
erate increase in BMP4. p.R206Q was found to associate with 
a mild increase in the expression of BMP4 only. GLI3‐de-
pendent SHH‐signaling pathway plays a critical role in de-
velopment of multiple organs including brain, neural tube, 
developing limbs, and the gut (Villavicencio, Walterhouse, & 
Lannaccone, 2000). We speculate that severe disturbance in 
SHH‐signaling genes likely play an important role in cranio-
facial anomalies and multiple organ malformations in these 
patients. We further speculate that differences in the expres-
sion profile of SHH‐signaling genes potentially contribute to 
variable expression of phenotypes in patients with MED12‐
related XLID syndromes.
The Ohdo syndrome is defined by several mutations in 
LS and PQL domains (p.R1148H, p.S1165P, p.A1383T, 
p.H1729N). Core clinical features of patients include mod-
erate to severe intellectual disability, autistic behaviors, cra-
niofacial anomalies such as microcephaly, blepharophimosis, 
prominent and bulbous nose, ear anomalies, and moderate to 
severe hypotonia. Skeletal, gastrointestinal, and genital uri-
nary anomalies that are common in the FG‐Lujan syndrome 
spectrum are relatively mild or absent in patients with Ohdo 
syndrome. The molecular mechanisms that underlie Ohdo 
syndrome have not been fully characterized. MED12 has also 
been found to play key roles in the regulation of REST‐depen-
dent epigenetic silencing of neuronal gene expression (Ding 
et al., 2008) and immediate early gene expression (Donnio 
et al., 2017). Systematic functional characterizations of these 
mutations are warranted.
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